These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8886173)

  • 1. Seasonal variation in the incidence of end-stage renal disease.
    Iseki K; Morita O; Fukiyama K
    Am J Nephrol; 1996; 16(5):375-81. PubMed ID: 8886173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seasonal blood pressure and body weight variation in patients on chronic hemodialysis.
    Tozawa M; Iseki K; Iseki C; Morita O; Yoshi S; Fukiyama K
    Am J Nephrol; 1999; 19(6):660-7. PubMed ID: 10592360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal variations in transition, mortality and kidney transplantation among patients with end-stage renal disease in the USA.
    Obi Y; Kalantar-Zadeh K; Streja E; Rhee CM; Reddy UG; Soohoo M; Wang Y; Ravel V; You AS; Jing J; Sim JJ; Nguyen DV; Gillen DL; Saran R; Robinson B; Kovesdy CP
    Nephrol Dial Transplant; 2017 Apr; 32(suppl_2):ii99-ii105. PubMed ID: 28201764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.
    Iseki K; Kinjo K; Iseki C; Takishita S
    Am J Kidney Dis; 2004 Nov; 44(5):806-14. PubMed ID: 15492946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing gender difference in the incidence of chronic dialysis therapy in Japan.
    Iseki K; Nakai S; Shinzato T; Nagura Y; Akiba T;
    Ther Apher Dial; 2005 Oct; 9(5):407-11. PubMed ID: 16202016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan.
    Iseki K; Ikemiya Y; Kinjo K; Iseki C; Takishita S
    Clin Exp Nephrol; 2004 Sep; 8(3):250-6. PubMed ID: 15480903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of serum creatinine values in new end-stage renal disease patients.
    Fink JC; Burdick RA; Kurth SJ; Blahut SA; Armistead NC; Turner MS; Shickle LM; Light PD
    Am J Kidney Dis; 1999 Oct; 34(4):694-701. PubMed ID: 10516351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
    Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
    Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan.
    Furumatsu Y; Nagasawa Y; Hamano T; Iwatani H; Iio K; Shoji T; Ito T; Tsubakihara Y; Imai E
    Nephrol Dial Transplant; 2008 Mar; 23(3):984-90. PubMed ID: 17956890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level of renal function at the initiation of dialysis in the U.S. end-stage renal disease population.
    Obrador GT; Arora P; Kausz AT; Ruthazer R; Pereira BJ; Levey AS
    Kidney Int; 1999 Dec; 56(6):2227-35. PubMed ID: 10594799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for high incidence of end-stage renal disease in patients after stroke and acute myocardial infarction at age 60 or younger.
    Iseki K; Wakugami K; Maehara A; Tozawa M; Muratani H; Fukiyama K
    Am J Kidney Dis; 2001 Dec; 38(6):1235-9. PubMed ID: 11728955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney Failure and ESRD in the Atherosclerosis Risk in Communities (ARIC) Study: Comparing Ascertainment of Treated and Untreated Kidney Failure in a Cohort Study.
    Rebholz CM; Coresh J; Ballew SH; McMahon B; Whelton SP; Selvin E; Grams ME
    Am J Kidney Dis; 2015 Aug; 66(2):231-9. PubMed ID: 25773483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional variations in the incidence of end-stage renal failure in Japan.
    Usami T; Koyama K; Takeuchi O; Morozumi K; Kimura G
    JAMA; 2000 Nov 22-29; 284(20):2622-4. PubMed ID: 11086370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic cholecystectomy for 58 end stage renal disease patients.
    Yeh CN; Chen MF; Jan YY
    Surg Endosc; 2005 Jul; 19(7):915-8. PubMed ID: 15868265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009.
    Butler AM; Olshan AF; Kshirsagar AV; Edwards JK; Nielsen ME; Wheeler SB; Brookhart MA
    Am J Kidney Dis; 2015 May; 65(5):763-72. PubMed ID: 25662835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of end-stage renal disease in Ile de France: a prospective epidemiological survey].
    Jungers P; Massy Z; Man NK; Labrunie M; Taupin P; Guin E; Landais P
    Presse Med; 2000 Mar; 29(11):589-92. PubMed ID: 10776412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal changes in blood pressure in patients with end-stage renal disease treated with hemodialysis.
    Argilés A; Mourad G; Mion C
    N Engl J Med; 1998 Nov; 339(19):1364-70. PubMed ID: 9801397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [End stage renal disease lymphopenia; characterization and clinical correlation].
    Lepe-Zúñiga JL; Morales-Molina P; García-Nandayapa GA
    Rev Med Inst Mex Seguro Soc; 2016; 54(4):446-53. PubMed ID: 27197101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.